Foyston Gordon & Payne Inc Lowers Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Foyston Gordon & Payne Inc reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 12.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,979 shares of the company’s stock after selling 18,867 shares during the period. Henry Schein makes up 2.3% of Foyston Gordon & Payne Inc’s portfolio, making the stock its 16th biggest holding. Foyston Gordon & Payne Inc owned about 0.10% of Henry Schein worth $9,257,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HSIC. M&T Bank Corp increased its stake in Henry Schein by 4.5% in the 3rd quarter. M&T Bank Corp now owns 10,990 shares of the company’s stock worth $802,000 after acquiring an additional 472 shares during the last quarter. Barclays PLC grew its holdings in shares of Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company’s stock worth $20,882,000 after purchasing an additional 18,458 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of Henry Schein by 1.0% in the third quarter. Nomura Asset Management Co. Ltd. now owns 38,816 shares of the company’s stock worth $2,830,000 after purchasing an additional 373 shares during the last quarter. MML Investors Services LLC raised its stake in Henry Schein by 5.1% in the third quarter. MML Investors Services LLC now owns 11,000 shares of the company’s stock valued at $802,000 after purchasing an additional 535 shares in the last quarter. Finally, Headinvest LLC bought a new stake in Henry Schein during the third quarter valued at approximately $207,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on HSIC shares. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $78.89.

Henry Schein Trading Up 2.7 %

NASDAQ:HSIC opened at $74.98 on Tuesday. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $71.83 and a 200-day moving average price of $69.92. The stock has a market cap of $9.35 billion, a price-to-earnings ratio of 30.86, a P/E/G ratio of 2.09 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the business posted $1.32 earnings per share. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.